HeyJaredMigraine Minute News Update
The Migraine Minute provides weekly updates in migraine research and news hosted by Molly O'Brien of the Association of Migraine Disorders.
- Indexed episodes, last 90 days
- 5
- Latest publication
- Sep 18, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 17, 2026
Latest episodes
Does Fertility Treatment Have an Impact on Headache? (opens the original)
Read excerpt
Could fertility treatment affect migraine and headache? A new review of more than 100 studies, published in the Journal of Headache and Pain, finds headache may be an overlooked and understudied side effect of fertility treatments. Molly O'Brien has more details in this Migraine Minute News Update. Read The Source: bit.ly/4hAFO6j Creative Commons: https://creativecommons.org/licenses/by/4.0/ Script: A new review draws attention to migraine and headache as a potentially overlooked side effect of
VA Expands Migraine Treatment Options for Veterans (opens the original)
Read excerpt
The US Department of Veterans Affairs will now cover the use of at-home neuromodulation devices for migraine and depression. Molly O'Brien has details in this Migraine Minute News Update. Read More: https://bit.ly/4bKB9uO Script: More treatment options for US Veterans with migraine and/or depression are now available and covered by the VA. This is promising news, as migraine and depression are some of the most common health conditions treated in the VA health system, with more than half a millio
Clinical Trial Shows Promise for Pipeline Episodic & Chronic Migraine Preventive (opens the original)
Read excerpt
Could a new migraine preventive treatment be on the horizon? A late-stage clinical trial shows promising new results for a migraine preventive in the pipeline. Molly O'Brien breaks it down in this Migraine Minute News Update. Link: https://bit.ly/3RFNARH FDA Drug Label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125274s125lbl.pdf#page=30 Script: Research shows promising new results in a late-stage clinical trial for a migraine preventive treatment in the pipeline. Biopharmaceutica
Migraine Oral Preventives Vs. Galcanezumab (opens the original)
Read excerpt
A real-world study suggests one migraine preventive may be more effective than some commonly prescribed oral treatments at three months. Molly O'Brien breaks down the study in this Migraine Minute News Update. Read More: https://bit.ly/3TpJmhM Creative Commons: https://creativecommons.org/licenses/by-nc-nd/4.0/ Script: New research published in Headache, the Journal of Head and Face Pain, shows that one CGRP MAB may be more effective than some traditional oral preventives. Triumph is an internat
Making OnabotulinumtoxinA Injections Less Painful (opens the original)
Read excerpt
Ever wonder if there was a way to make OnabotulinumtoxinA injections less painful? New research suggests using this treatment before injections may help. Molly O'Brien explains in this Migraine Minute news update. Read the study: https://bit.ly/4wRHAFh Script: For many people with chronic migraine, onabotulinumtoxinA, also known as Botox, is an effective treatment, but it can come with injection pain and post-treatment headache. New research shows there may be an option to help ease that pain. A
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Not enough subject data for this period yet.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.